Gastrointestinal Cancer Surgery
Hospital Germans Trias I Pujol is involved in clinical research on total gastrectomy for cancer, with attention to postoperative esophagojejunal anastomosis integrity and related surgical complications.
- Esophagojejunal anastomosis dehiscence
- Total gastrectomy
- Oncologic surgery
The sponsor’s activity in this area centers on surgical outcomes and tissue healing in upper gastrointestinal cancer care.
Multiple Sclerosis
The hospital also supports research in multiple sclerosis, including progressive forms of MS and immune-targeted approaches linked to neurological disease management.
- Progressive multiple sclerosis
- Neurology
- Disability progression
This area reflects an interest in chronic neuroinflammatory disease and clinical measures of functional change.
Cell-Based Immunotherapy
Research activity includes tolerogenic dendritic cells and autologous cell-based therapy, indicating a focus on immune modulation in complex disease settings.
- Tolerogenic dendritic cells
- Autologous immunotherapy
- Antigen-specific treatment
These studies place the sponsor within the field of advanced cell therapy for immune-mediated disorders.
Surgical and Regenerative Support in Oncology
The sponsor’s oncology-related research also extends to approaches aimed at improving anastomotic healing and reducing postoperative complications after major digestive surgery.
- Fibrin-based adhesive
- Postoperative healing
- Digestive tract surgery
This area links gastrointestinal surgery with biomaterial-supported strategies for tissue repair.
